527 related articles for article (PubMed ID: 30738142)
1. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E
Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142
[TBL] [Abstract][Full Text] [Related]
2. Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.
Barone E; Di Domenico F; Cassano T; Arena A; Tramutola A; Lavecchia MA; Coccia R; Butterfield DA; Perluigi M
Free Radic Biol Med; 2016 Feb; 91():127-42. PubMed ID: 26698666
[TBL] [Abstract][Full Text] [Related]
3. TPPU protects tau from H
Yao ES; Tang Y; Liu XH; Wang MH
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
[TBL] [Abstract][Full Text] [Related]
5. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA
J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β.
Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ
Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563
[TBL] [Abstract][Full Text] [Related]
7. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.
Farr SA; Ripley JL; Sultana R; Zhang Z; Niehoff ML; Platt TL; Murphy MP; Morley JE; Kumar V; Butterfield DA
Free Radic Biol Med; 2014 Feb; 67():387-95. PubMed ID: 24355211
[TBL] [Abstract][Full Text] [Related]
9. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
10. Grape seed proanthocyanidins ameliorate neuronal oxidative damage by inhibiting GSK-3β-dependent mitochondrial permeability transition pore opening in an experimental model of sporadic Alzheimer's disease.
Sun Q; Jia N; Li X; Yang J; Chen G
Aging (Albany NY); 2019 Jun; 11(12):4107-4124. PubMed ID: 31232699
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
12. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
Jiang Y; Zhang Y; Su L
Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
[TBL] [Abstract][Full Text] [Related]
13. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration.
Zhou Q; Li S; Li M; Ke D; Wang Q; Yang Y; Liu GP; Wang XC; Liu E; Wang JZ
EBioMedicine; 2022 Apr; 78():103970. PubMed ID: 35339896
[TBL] [Abstract][Full Text] [Related]
14. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
15. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
16. Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation.
Kanno T; Tsuchiya A; Tanaka A; Nishizaki T
Mol Neurobiol; 2016 Sep; 53(7):4787-97. PubMed ID: 26328540
[TBL] [Abstract][Full Text] [Related]
17. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
18. Tannoid principles of Emblica officinalis attenuated aluminum chloride induced apoptosis by suppressing oxidative stress and tau pathology via Akt/GSK-3βsignaling pathway.
Justin Thenmozhi A; Dhivyabharathi M; Manivasagam T; Essa MM
J Ethnopharmacol; 2016 Dec; 194():20-29. PubMed ID: 27566203
[TBL] [Abstract][Full Text] [Related]
19. Biliverdin Reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β.
Lanzillotta C; Tramutola A; Lanzillotta S; Greco V; Pagnotta S; Sanchini C; Di Angelantonio S; Forte E; Rinaldo S; Paone A; Cutruzzolà F; Cimini FA; Barchetta I; Cavallo MG; Urbani A; Butterfield DA; Di Domenico F; Paul BD; Perluigi M; Duarte JMN; Barone E
Redox Biol; 2024 Jul; 73():103221. PubMed ID: 38843768
[TBL] [Abstract][Full Text] [Related]
20. TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro.
Peng X; Guo H; Zhang X; Yang Z; Ruganzu JB; Yang Z; Wu X; Bi W; Ji S; Yang W
Mol Neurobiol; 2023 May; 60(5):2470-2485. PubMed ID: 36662361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
